Correlation between genotype and phenotype in hereditary hemochromatosis: Analysis of 61 cases

This report assesses the degree of iron overload in a cohort of patients in relationship to the presence or absence of the recently described 845 G-->A (C282Y) and 187 C-->G (H63D) mutations in the HFE (HLA-H) gene, Sixty-one patients with hereditary hemochromatosis diagnosed either with liver biopsy or on clinical grounds were included in this analysis, Forty-one patients were homozygous for C282Y, the genotype considered to be characteristic of hereditary hemochromatosis, At the time of this analysis, 37 of these 41 patients had achieved a state of iron depletion and mobilizable iron was calculated; 19 had less than 4 grams. Twenty-Five of these 41 patients had liver biopsies; 4 of these patients had a hepatic iron index less than 1.9, Of the 4 patients with a normal hepatic iron index, 3 had a quantitative hepatic iron of greater than 50 mu mol/g dry weight, and one had an inadequate biopsy sample. These findings support our suspicion that individuals may have hereditary hemochromatosis and homozygous C282Y despite relatively low body iron stores, Five patients were compound heterozygotes for C282Y and H63D. Four of these patients underwent liver biopsy; two had a hepatic iron index greater than 1.9. A third patient had a hepatic iron index of 1.3 but a quantitative hepatic iron of 90.6 mu mol/g dry weight. All patients were phlebotomized to a state of iron depletion and only one of these patients had a mobilizable iron greater than 4 grams, Three patients were homozygous for H63D; these patients had either a hepatic iron index >1.9 or greater than 4 grams of mobilizable iron. Patients with homozygous H63D and significant iron overload are not well described. Seven patients were heterozygous for either C282Y or H63D; 4 had significant iron overload but three did not. Five patients had no HFE mutations; one of these patients unequivocally has iron overload with a hepatic iron index of 4.4, We conclude that: (1) Identification of HFE mutations will be clinically useful in identifying patients with hereditary hemochromatosis, (2) Patient genotyping will help confirm a diagnosis of hereditary hemochromatosis in some patients with relatively low body iron stores, (3) Significant iron loading can occur in the absence of homozygous C282Y, adding to the evidence that genes other than HFE may be involved in iron loading, and (4) Homozygous H63D can be associated with significant iron overload.